GDR remains POC of choice!!!31 Jul 2024 02:13
"There are likely to be considerable barriers to implementing laboratory-based testing for
everyone who has had an ischaemic stroke or a TIA. If laboratory-based testing is not
available, or it will take a long time to develop capacity to provide it, then point-of-care
tests could be used. So, the Genedrive CYP2C19 ID Kit should be used when laboratory-
based testing is not available."!!!!!
Considering there is a handful number of labs only around country...and straight recommendation "while lab not available" GDR is the choice....that seals it
Remember the aim of todays guideline vs draft was NOT GDR vS Lab.... It was whether GDR still remains POC of choice!!! And it remains despite numerous submission and genomadix trying there best (see documents) even reducing cost of genomadix and providing free freezer etc... yet NICE took all that on board and GDR is STILL njmber one choice GDR vs Genomadix..... π₯π₯π₯π₯π₯π₯π₯π₯π₯